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Abstract 
The interactions of single nucleotide polymorphisms (SNPs) and cigarette smoking on blood 
pressure levels are limited. The present study was undertaken to detect nine lipid-related 
SNPs and their interactions with cigarette smoking on blood pressure levels. Genotyping of 
ATP-binding cassette transporter A1 (ABCA-1) V825I, acyl-CoA:cholesterol acyltransfer-
ase-1 (ACAT-1) rs1044925, low density lipoprotein receptor (LDL-R) AvaⅡ, hepatic lipase 
gene (LIPC) -250G>A, endothelial lipase gene (LIPG) 584C>T, methylenetetrahydrofolate 
reductase (MTHFR) 677C>T, proprotein convertase subtilisin-like kexin type 9 (PCSK9) 
E670G, peroxisome proliferator-activated receptor delta (PPARD) +294T>C, and Scavenger 
receptor class B type 1 (SCARB1) rs5888 was performed in 935 nonsmokers and  845 
smokers. The interactions were detected by factorial regression analysis. The frequencies of 
genotypes (ACAT-1 and LIPG), alleles (ABCA-1), and both genotypes and alleles (LDL-R, 
LIPC,  PPARD  and  SCARB1)  were  different  between  nonsmokers  and  smokers  (P  < 
0.05–0.001). The levels of pulse pressure (PP, ABCA-1), and systolic, diastolic blood pressure 
(SBP,  DBP)  and  PP  (LIPC)  in  nonsmokers  were  different  among  the  genotypes  (P  < 
0.01-0.001). The levels of SBP (ABCA-1, ACAT-1, LIPG and PCSK9), DBP (ACAT-1, LDL-R, 
LIPC, PCSK9 and PPARD), and PP (LIPC, LIPG, MTHFR and PCSK9) in smokers were dif-
ferent among the genotypes (P < 0.01-0.001). The SNPs of ABCA-1, ACAT-1 and PCSK9; 
ACAT-1, LDL-R, MTHFR and PCSK9; and ABCA-1, LIPC, PCSK9 and PPARD were shown 
interactions with cigarette smoking to influence SBP, DBP and PP levels (P < 0.05-0.001); 
respectively. The differences in blood pressure levels between the nonsmokers and smokers 
might partly result from different interactions of several SNPs and cigarette smoking. 
Key words: blood pressure; hypertension; genetic polymorphism; cigarette smoking; interaction. 
Introduction 
Hypertension is a complex disease that affects 1 
billion  people  and  causes  more  than  7.1  million 
premature  deaths  a  year  worldwide  [1].  It  is 
well-recognized that blood pressure is modulated by 
multiple  genetic  loci  as  well  as  environmental  and 
lifestyle factors including diet, smoking habits, obe-
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sity and physical inactivity [2,3], and their interactions 
[4-9]. Many previous genome-wide association stud-
ies (GWAS) in different populations have simultane-
ously explored a large number of genomic loci asso-
ciated with blood pressure and hypertension, but the 
results  of  these  association  studies  conducted  with 
blood pressure traits have been inconsistent [10-18]. A 
major reason for inconsistency among studies may be 
different environmental modifiers that interact with 
genes to influence blood pressure and hypertension. 
Although  the  deleterious  effects  of  cigarette 
smoking  on  the  cardiovascular  system  have  been 
clearly  documented,  the  relationship  between  ciga-
rette smoking and blood pressure and hypertension 
has  not  been  fully  characterized  [19].  Some  studies 
have  reported  that  cigarette  smoking  is  associated 
with increased blood pressure [20-22], others reported 
associations  with  decreased  blood  pressure  [23-25], 
while some found no effect at all [26,27]. However, 
cigarette smoking has proven to be an important me-
diator of genetic effects in association studies of blood 
pressure and hypertension [4-9]. 
There are 56 ethnic groups in China. Yao is the 
eleventh  largest  minority  among  the  55  minority 
groups according to the population size. Bai Ku Yao 
(White-trouser Yao), an isolated subgroup of the Yao 
minority, is named so because all of men wear white 
knee-length  knickerbockers.  The  population  size  is 
about 30 000. Because of isolation from the other eth-
nic groups, the special customs and cultures including 
their  clothing,  intra-ethnic  marriages,  dietary  pat-
terns, and corn wine and rum intakes are still com-
pletely preserved to the present day. In previous ep-
idemiological studies, we found that the prevalence of 
hypertension  was  higher  in  smokers  than  in  non-
smokers  [2,3]. Since  hypertension  is  found  to  occur 
more  often  than  expected  in  families  with  familial 
combined hyperlipidemia and other types of familial 
lipid syndromes [28], genes involved in lipid metabo-
lism may be involved in the genetic component of the 
development of hypertension. Therefore, the aim of 
the present study was to detect nine single nucleotide 
polymorphisms  (SNPs)  in  different  lipid-related 
genes  and  evaluate  their  interactions  with  cigarette 
smoking on blood pressure levels in the Guangxi Bai 
Ku Yao population. 
Materials and Methods 
Subjects 
A total of 1780 unrelated subjects of Bai Ku Yao 
who  reside  in  Lihu  and  Baxu  villages  in  Nandan 
County, Guangxi Zhuang Autonomous Region, Peo-
ple’s Republic of China were randomly selected from 
our  previous  stratified  randomized  cluster  samples 
[2,3].  The  age  of  the  subjects  ranged  from  15  to  80 
years,  with  an  average  age  of  41.60  ±  16.43  years. 
There were 935 nonsmokers (285 males and 650 fe-
males) and 845 smokers (709 males and 136 females). 
All  of  the  subjects  were  rural  agricultural  workers. 
The subjects had no evidence of diseases related to 
atherosclerosis, coronary artery disease and diabetes. 
None of them had been treated with antihypertensive 
drugs,  such  as  nifedipine  and/or  catopril  and  li-
pid-lowering drugs. The study design was approved 
by the Ethics Committee of the First Affiliated Hos-
pital,  Guangxi  Medical  University.  All  participants 
have given written informed consent. 
Epidemiological survey 
The survey was done according to standardized 
methods. Information on personal and demographic 
characteristics, personal and family history of disease, 
current pharmacotherapy, cigarette smoking, alcohol 
consumption, and physical activity was  obtained at 
interview.  Self-reported  information  on  cigarette 
smoking was recorded. All participants were asked, 
―Have you smoked at least 100 cigarettes in your en-
tire life?‖ and ―Do you now smoke cigarettes every 
day, some days  or not at  all?‖ Smoking status  was 
re-coded as: ―Smokers‖ or ―current smokers‖ if the 
respondents  reported  having  smoked  at  least  100 
cigarettes in their lifetime and were current smokers 
either  every  day  or  some  days;  ―nonsmokers‖  or 
―never  smokers‖  if  they  reported  they  had  not 
smoked at least 100 cigarettes in  their  lifetime; and 
―former smokers‖ if they reported having smoked 100 
cigarettes in their lifetime but did not currently smoke 
[29,30]. ―Former smokers‖ were not included in this 
study.  Sitting  blood  pressure  was  measured  three 
times by a well-trained physician with the use of a 
standard mercury sphygmomanometer after the sub-
ject  rested  5  minutes,  and  the  average  of  the  three 
measurements was used for the level of blood pres-
sure. Systolic blood pressure (SBP) was determined by 
the first Korotkoff sound, and diastolic blood pressure 
(DBP)  by  the  fifth  Korotkoff  sound.  Pulse  pressure 
(PP) was calculated as the systolic minus the diastolic 
blood pressure. Body weight, to the nearest 50 grams, 
was measured using a portable balance scale. Subjects 
were weighed without shoes and in a minimum of 
clothing. Height was measured, to the nearest 0.5 cm, 
using a portable steel measuring device. From these 
two  measurements  body  mass  index  (BMI,  kg/m2) 
was  calculated.  Waist  circumference  was  measured 
with a nonstretchable measuring tape, at the level of 
the smallest area of the waist, to the nearest 0.1 cm. Int. J. Biol. Sci. 2012, 8 
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Measurements of lipids and apolipoproteins 
A venous blood sample of 5 mL was obtained 
from all subjects after at least 12 hours of fasting. A 
part  of  the  sample  (2  mL)  was  collected  into  glass 
tubes and used to determine serum lipid levels. An-
other  part  of  the  sample  (3  mL)  was  transferred  to 
tubes with anticoagulate solution and used to extract 
deoxyribonucleic acid (DNA). The levels of total cho-
lesterol (TC), triglyceride (TG), high-density lipopro-
tein cholesterol (HDL-C), and low-density lipoprotein 
cholesterol (LDL-C) in samples were determined by 
enzymatic methods. Serum apolipoprotein (Apo) A1 
and ApoB levels were detected by the immunoturbi-
dimetric immunoassay. All determinations were per-
formed  with  an  autoanalyzer  (Type  7170A;  Hitachi 
Ltd., Tokyo, Japan) in our Clinical Science Experiment 
Center [31,32]. 
Genotyping 
Genomic DNA was extracted from the peripher-
al blood leukocytes by the phenol-chloroform method 
as  our  previous  reports  [33-40].  Genotyping  of 
ATP-binding cassette transporter A1 (ABCA-1) V825I 
(rs2066715),  acyl-CoA:cholesterol  acyltransferase-1 
(ACAT-1) rs1044925, low density lipoprotein receptor 
(LDL-R) AvaⅡ, hepatic lipase gene (LIPC) -250G>A 
(rs2070895),  endothelial  lipase  gene  (LIPG)  584C>T 
(rs2000813),  methylenetetrahydrofolate  reductase 
(MTHFR) 677C>T (rs1801133), proprotein convertase 
subtilisin-like kexin type 9 (PCSK9) E670G (rs505151), 
peroxisome  proliferator-activated  receptor  delta 
(PPARD) +294T>C (rs2016520) and Scavenger recep-
tor  class  B  type  1  (SCARB1)  rs5888  was  performed 
using  polymerase  chain  reaction  and  restriction 
fragment length polymorphism (PCR-RFLP). The se-
quences  of  the  forward  and  backward  primers  and 
restriction  ezyme  used  for  the  genotyping  of  nine 
SNPs,  the  thermocycling  protocol,  the  approach  to 
electrophoresis, and the procedures for quality control 
have  been  described  previously  [33-40].  Genotypes 
were scored by an experienced reader blinded to ep-
idemiological data and blood pressure levels. 
Diagnostic criteria 
Hypertension was defined as an average SBP of 
140 mmHg or greater and/or an average DBP of 90 
mmHg or greater [2,3]. The normal values of serum 
TC, TG, HDL-C, LDL-C, ApoA1 and ApoB levels, and 
the ratio of ApoA1 to ApoB in our Clinical Science 
Experiment  Center  were  3.10–5.17,  0.56–1.70, 
0.91–1.81, 2.70–3.20 mmol/L, 1.00–1.78, 0.63–1.14 g/L, 
and 1.00–2.50; respectively [31,32]. 
Statistical analysis 
Quantitative variables were presented as mean ± 
SD or percentage. All statistical analyses were done 
with the statistical software package SPSS 13.0 (SPSS 
Inc.,  Chicago,  Illinois,  USA).  Chi  square  tests  were 
used to compare the differences in percentages and to 
assess Hardy-Weinberg expectations, whereas analy-
sis of covariance (ANOVA) was used to compare the 
differences in various continuous variables between 
respective  comparison  groups.  The  sex,  age,  educa-
tion level, physical activity, BMI, waist circumference, 
alcohol  consumption,  and  hyperlipidemia  were  ad-
justed for the statistical analyses. All significant asso-
ciations were corrected for multiple testing by apply-
ing a Bonferroni correction. The allelic and genotypic 
frequencies were calculated from the observed geno-
typic counts. The interactions of nine SNPs and ciga-
rette smoking on blood pressure levels were assessed 
by using a factorial regression analysis after control-
ling for potential confounders including sex, age, ed-
ucation  level,  physical  activity,  BMI,  waist  circum-
ference,  alcohol  consumption,  and  hyperlipidemia. 
Multiple linear regression was used to ascertain the 
correlation between genotypes (ABCA-1 V825I: GG = 
1, GA = 2, AA = 3; ACAT-1 rs1044925: AA = 1, AC = 2, 
CC = 3; LDL-R AvaⅡ: A-A- = 1, A-A+ = 2, A+A+ = 3; 
LIPC -250G>A: GG = 1, GA = 2, AA = 3; LIPG 584C>T: 
CC = 1, CT = 2, TT = 3; MTHFR 677C>T: CC = 1, CT = 
2, TT = 3; PCSK9 E670G: AA = 1, AG = 2; PPARD 
+294T>C: TT = 1, TC = 2, CC = 3; SCARB1 rs5888: CC 
= 1, CT = 2, TT = 3) or alleles (the minor allele non-
carrier  =  1,  the  minor  allele  carrier  =  2)  and  blood 
pressure levels in the combined population of non-
smokers  and  smokers,  nonsmokers,  and  smokers; 
respectively. 
Results 
General characteristics between nonsmokers 
and smokers 
As shown in Table 1, the levels of average age, 
height,  weight,  waist  circumference,  SBP,  DBP,  hy-
pertensive prevalence, TC, TG, HDL-C, ApoA1; the 
ratio of ApoA1 to ApoB; the percentages of subjects 
who consumed alcohol; and the ratio of males to fe-
males were higher in smokers than in nonsmokers (P 
< 0.05–0.001). There were no significant differences in 
the  levels  of  education,  BMI,  PP,  LDL-C and  ApoB 
between smokers and nonsmokers (P > 0.05 for all). 
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Table 1. The general characteristics and blood pressure levels between the nonsmokers and smokers. 
Characteristics  Nonsmoker 
(n = 935) 
Smoker 
(n = 845) 
t (χ2)  p 
Age (years)  39.75±16.31  43.64±16.32  -5.023  0.000 
Male/female  285/650  709/136  513.751  0.000 
Education level (years)  6.20±3.26  6.31±3.16  0.721  0.471 
Height (cm)  151.73±7.39  158.13±7.28  -18.378  0.000 
Weight (kg)  51.40±8.09  55.07±8.50  -9.311  0.000 
Body mass index (kg/m2)  22.30±2.90  22.10±2.53  1.559  0.119 
> 24 kg/m2 [n(%)]  223 (23.9)  134 (15.9)  17.683  0.000 
Waist circumference (cm)  71.84±8.84  74.23±8.12  5.920  0.000 
Alcohol consumption [n (%)]  246 (26.3)  602 (71.2)  361.471  0.000 
Systolic blood pressure (SBP, mmHg)  119.20±17.31  122.78±15.50  -4.606  0.000 
SBP ≥ 140 mmHg [n (%)]  110 (11.8)  121 (14.3)  2.565  0.109 
Diastolic blood pressure (DBP, mmHg)  74.87±10.37  77.63±9.47  -5.882  0.000 
DBP ≥ 90 mmHg [n (%)]  111 (11.9)  106 (12.5)  0.188  0.665 
Pulse pressure (mmHg)  44.34±11.96  45.16±11.77  -1.463  0.144 
Hypertensive prevalence [n (%)]  151 (16.1)  169 (20.0)  4.462  0.035 
Total cholesterol (mmol/L)  4.48±0.93  4.60±1.06  -2.653  0.008 
Triglycerides (mmol/L)  1.23±1.08  1.38±1.24  -2.686  0.007 
HDL-C (mmol/L)  1.74±0.46  1.84±0.49  -4.153  0.000 
LDL-C (mmol/L)  2.59±0.69  2.59±0.87  -0.101  0.920 
Apolipoprotein (Apo) A1 (g/L)  1.33±0.29  1.41±0.33  -5.694  0.000 
ApoB (g/L)  0.86±0.22  0.88±0.23  -1.646  0.101 
ApoA1/ApoB  1.64±0.59  1.73±0.74  -2.878  0.004 
 
Genotypic and allelic frequencies between 
nonsmokers and smokers 
The genotypic and allelic frequencies of the nine 
SNPs between nonsmokers and smokers are shown in 
Table 2. The genotypic distribution of nine SNPs was 
consistent with the Hardy-Weinberg equilibrium. The 
genotypic  and  allelic  frequencies  of  LDL-R,  LIPC, 
PPARD  and  SCARB1  were  different  between  non-
smokers and smokers (P < 0.05–0.001). The genotypic 
frequencies of ACAT-1 and LIPG, and the allelic fre-
quencies  of  ABCA-1  were  also  different  between 
nonsmokers and smokers (P < 0.05 for all). There were 
no significant differences in the genotypic and allelic 
frequencies  of  MTHFR  and  PCSK9  between  non-
smokers and smokers (P < 0.05 for all). The GG ho-
mozygous of the PCSK9 E670G was not detected in 
our study population. 
Genotypes and blood pressure levels between 
nonsmokers and smokers 
The association of genotypes and blood pressure 
levels between nonsmokers and smokers is shown in 
Figure 1. The levels of PP in  nonsmokers were dif-
ferent  among  the  three  genotypes  of  ABCA-1  (P < 
0.01), and the levels of SBP, DBP and PP in nonsmok-
ers were also different among the three genotypes of 
LIPC (P < 0.01-0.001). 
For the smokers, the levels of SBP were different 
among  the  three  genotypes  of  ABCA-1,  ACAT-1, 
LIPG and PCSK9 (P < 0.01-0.001), the levels of DBP 
were different among the three genotypes of ACAT-1, 
LDL-R, LIPC, PCSK9 and PPARD (P < 0.01-0.001), and 
the levels of PP were different among the three geno-
types  of  LIPC,  LIPG,  MTHFR  and  PCSK9  (P  < 
0.01-0.001). 
Interactions of several SNPs and cigarette 
smoking on blood pressure levels 
The  interactions  of  nine  SNPs  and  cigarette 
smoking on blood pressure levels are given in Table 3. 
The genotypes of ABCA-1 GG and GA and ACAT-1 
AA and AC were shown interactions with cigarette 
smoking to increase SBP levels, whereas the genotype 
of PCSK9 AG was shown interactions with cigarette 
smoking to decrease SBP levels (P < 0.05-0.001). The 
genotypes of ACAT-1 AA and AC, LDL-R A-A-, A-A+ 
and A+A+, MTHFR CC and CT, and PCSK9 AA were 
shown consistent interactions with cigarette smoking 
to increase DBP levels (P < 0.05-0.01). The genotypes 
of ABCA-1 GA and LIPC GG were shown interactions 
with cigarette smoking to increase PP levels, whereas 
the genotypes of PCSK9 AA and AG, and PPARD CC 
were  shown  interactions  with  cigarette  smoking  to Int. J. Biol. Sci. 2012, 8 
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decrease PP levels (P < 0.05-0.001). 
Correlation between genotypes or alleles and 
blood pressure levels 
The results of multiple linear regression analysis 
between genotypes or alleles and blood pressure lev-
els  are  shown  in  Table  4.  For  the  nonsmokers,  the 
levels of SBP were associated with the genotypes of 
LIPC  (P <  0.01);  the  levels  of  DBP  were  associated 
with  the  genotypes  and/or  alleles  of  LIPG  and 
PPARD (P < 0.05 for all); and the levels of PP were 
associated with the genotypes and/or alleles of LIPC 
(P < 0.05 for each). 
For the smokers, the levels of SBP were corre-
lated with the genotypes and/or alleles of ABCA-1, 
LIPG and PCSK9 (P < 0.01 for all), the levels of DBP 
were correlated with the genotypes and/or alleles of 
ABCA-1, ACAT-1, LDL-R and PCSK9 (P < 0.05-0.001), 
and the levels of PP were correlated with the geno-
types and/or alleles of ABCA-1, LIPC, LIPG, MTHFR 
and PCSK9 (P < 0.05-0.001). 
 
 
Figure 1. The genotypes of nine SNPs and blood pressure levels between the nonsmokers and smokers. aP < 0.01, bP < 
0.005, and cP < 0.001. Int. J. Biol. Sci. 2012, 8 
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Table 2. The genotypic and allelic frequencies between nonsmokers and smokers. 
SNP  Genotype 
(Allele) 
Nonsmoker 
(n = 935) 
Smoker 
(n = 845) 
P Value 
ABCA-1 V825I  GG  307(32.8)  308(36.5)   
  GA  448(47.9)  399(47.2)   
  AA  180(19.3)  138(16.3)  0.146 
  G  1062(56.8)  1015(60.1)   
  A  808(43.2)  675(39.9)  0.048 
ACAT-1 rs1044925  AA  660(70.6)  592(70.1)   
  AC  252(27.0)  213(25.2)   
  CC  23(2.4)  40(4.7)  0.030 
  A  1572(84.1)  1397(82.7)   
  C  298(15.9)  293(17.3)  0.262 
LDL-R AvaⅡ  A-A-  468(50.1)  378(44.7)   
  A-A+  422(45.1)  301(35.6)   
  A+A+  45(4.8)  166(19.7)  0.000 
  A-  1358(72.6)  1057(62.5)   
  A+  512(27.4)  633(37.5)  0.000 
LIPC -250G>A  GG  433(46.3)  350(41.4)   
  GA  433(46.3)  350(41.4)   
  AA  69(7.4)  145(17.2)  0.000 
  G  1299(69.5)  1050(62.1)   
  A  571(30.5)  640(37.9)  0.000 
LIPG 584C>T  CC  432(46.2)  362(42.8)   
  CT  469(50.2)  430(50.9)   
  TT  34(3.6)  53(6.3)  0.024 
  C  1333(71.3)  1154(68.3)   
  T  537(28.7)  536(31.7)  0.051 
MTHFR 677C>T  CC  431(46.1)  416(49.2)   
  CT  437(46.7)  367(43.5)   
  TT  67(7.2)  62(7.3)  0.340 
  C  1299(69.5)  1199(70.9)   
  T  571(30.5)  491(29.1)  0.335 
PCSK9 E670G  AA  892(95.4)  793(93.8)   
  AG  43(4.6)  52(6.2)   
  GG  0(0)  0(0)  0.145 
  A  1827(97.7)  1638(96.9)   
  G  43(2.3)  52(3.1)  0.151 
PPARD +294T>C  TT  517(55.3)  496(58.7)   
  TC  347(37.1)  313(37.0)   
  CC  71(7.6)  36(4.3)  0.011 
  T  1381(73.9)  1305(77.2)   
  C  489(26.1)  385(22.8)  0.020 
SCARB1 rs5888  CC  534(57.1)  408(48.3)   
  CT  367(39.3)  371(43.9)   
  TT  34(3.6)  66(7.8)  0.000 
  C  1435(76.7)  1187(70.2)   
  T  435(23.3)  503(29.8)  0.000 
SNP: single nucleotide polymorphism; ABCA-1: ATP-binding cassette transporter A1; ACAT-1: acyl-CoA:cholesterol acyltransferase-1; 
LDL-R: low density lipoprotein receptor; LIPC: hepatic lipase gene; LIPG: endothelial lipase gene; MTHFR: methylenetetrahydrofolate 
reductase; PCSK9: proprotein convertase subtilisin-like kexin type 9; PPARD: peroxisome proliferator-activated receptor delta; SCARB1: 
Scavenger receptor class B type 1. 
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Table 3. Interactions of several single nucleotide polymorphisms and cigarette smoking on blood pressure levels. 
SNP  Genotype 
(F/P) 
SBP  DBP  PP 
ABCA-1 V825I  GG  ↑  –  – 
  GA  ↑  –  ↑ 
  AA  –  –  – 
  F  3.918  1.168  3.739 
  P  0.020  0.311  0.024 
ACAT-1 rs1044925  AA  ↑  ↑  – 
  AC  ↑  ↑  – 
  CC  –  –  – 
  F  3.677  4.293  1.043 
  P  0.026  0.014  0.353 
LDL-R AvaⅡ  A-A-  –  ↑  – 
  A-A+  –  ↑  – 
  A+A+  –  ↑  – 
  F  0.458  4.717  0.950 
  P  0.633  0.009  0.387 
LIPC -250G>A  GG  –  –  ↑ 
  GA  –  –  – 
  AA  –  –  – 
  F  0.761  1.424  4.514 
  P  0.467  0.241  0.011 
LIPG 584C>T  CC  –  –  – 
  CT  –  –  – 
  TT  –  –  – 
    0.582  0.035  1.446 
    0.559  0.965  0.236 
MTHFR 677C>T  CC  –  ↑  – 
  CT  –  ↑  – 
  TT  –  –  – 
  F  0.097  3.266  2.068 
  P  0.908  0.038  0.127 
PCSK9 E670G  AA  –  ↑  ↓ 
  AG  ↓  –  ↓ 
  F  18.610  3.847  15.401 
  P  0.000  0.050  0.000 
PPARD +294T>C  TT  –  –  – 
  TC  –  –  – 
  CC  –  –  ↓ 
  F  0.919  1.322  4.738 
  P  0.399  0.267  0.009 
SCARB1 rs5888  CC  –  –  – 
  CT  –  –  – 
  TT  –  –  – 
  F  1.058  1.055  1.607 
  P  0.347  0.349  0.201 
SNP: single nucleotide polymorphism; ABCA-1: ATP-binding cassette transporter A1; ACAT-1: acyl-CoA:cholesterol acyltransferase-1; 
LDL-R: low density lipoprotein receptor; LIPC: hepatic lipase gene; LIPG: endothelial lipase gene; MTHFR: methylenetetrahydrofolate 
reductase; PCSK9: proprotein convertase subtilisin-like kexin type 9; PPARD: peroxisome proliferator-activated receptor delta; SCARB1: 
Scavenger receptor class B type 1; ↑: genotype and cigarette smoking interactions to increase blood pressure; ↓: genotype and cigarette 
smoking interactions to decrease blood pressure; –: no interaction of genotype and cigarette smoking on blood pressure. 
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Table 4. Correlation between genotypes or alleles and blood pressure levels in the nonsmokers and smokers. 
BP  Genotype/allele  Unstandardized 
coefficient 
Std. error  Standardized 
coefficient 
t  P 
Both             
SBP  ABCA-1 V825I allele  -1.584  0.717  -0.045  -2.209  0.027 
  LIPC -250G>A genotype  2.137  0.488  0.090  4.376  0.000 
  LIPC -250G>A allele  1.337  0.661  0.042  2.021  0.043 
  LIPG 584C>T allele  1.790  0.730  0.051  2.453  0.014 
  MTHFR 677C>T genotype  1.045  0.428  0.055  2.440  0.015 
  MTHFR 677C>T allele  1.167  0.532  0.050  2.194  0.028 
  PCSK9 E670G genotype  -5.389  1.767  -0.063  -3.050  0.002 
             
DBP  ACAT-1 rs1044925 genotype  1.025  0.314  0.074  3.265  0.001 
  ACAT-1 rs1044925 allele  1.265  0.373  0.077  3.392  0.001 
  LIPC -250G>A genotype  1.308  0.321  0.089  4.070  0.000 
  LIPC -250G>A allele  1.118  0.435  0.056  2.570  0.010 
  LIPG 584C>T genotype  1.034  0.390  0.057  2.655  0.008 
  LIPG 584C>T allele  1.323  0.454  0.063  2.914  0.004 
  PPARD +294T>C allele  -1.025  0.459  -0.050  -2.231  0.026 
             
PP  MTHFR 677C>T genotype  0.739  0.360  0.470  2.053  0.040 
  PCSK9 E670G genotype  -4.655  1.389  -0.069  3.350  0.001 
Nonsmoker             
SBP  LIPC -250G>A genotype  2.192  0.751  0.085  2.920  0.004 
             
DBP  LIPG 584C>T genotype  1.195  0.562  0.063  2.214  0.034 
  LIPG 584C>T allele  1.466  0.637  0.069  2.303  0.022 
  PPARD +294T>C allele  -1.361  0.652  -0.065  -2.089  0.037 
             
PP  LIPC -250G>A genotype  1.838  0.572  0.099  3.211  0.001 
  LIPC -250G>A allele  1.544  0.716  0.067  2.158  0.031 
             
Smoker             
SBP  ABCA-1 V825I genotype  -2.077  0.671  -0.094  -3.098  0.002 
  ABCA-1 V825I allele  -2.669  0.976  -0.083  -2.735  0.006 
  LIPG 584C>T allele  2.560  0.963  0.081  2.659  0.008 
  PCSK9 E670G genotype  -11.804  2.139  -0.164  -5.519  0.000 
             
DBP  ABCA-1 V825I genotype  -0.934  0.441  -0.069  -2.118  0.034 
  ABCA-1 V825I allele  -1.431  0.641  -0.073  -2.231  0.026 
  ACAT-1 rs1044925 genotype  1.533  0.433  0.119  3.543  0.000 
  ACAT-1 rs1044925 allele  2.336  0.535  0.146  4.363  0.000 
  LDL-R AvaⅡallele  -1.184  0.581  -0.066  -2.039  0.042 
  PCSK9 E670G genotype  -2.923  1.469  -0.064  -1.989  0.047 
             
PP  ABCA-1 V825I genotype  -1.179  0.527  -0.070  -2.237  0.026 
  LIPC -250G>A allele  -1.731  0.715  -0.077  -2.421  0.016 
  LIPG 584C>T allele  1.534  0.726  0.069  2.113  0.035 
  MTHFR 677C>T genotype  1.226  0.545  0.075  2.249  0.025 
  PCSK9 E670G genotype  -9.643  1.670  -0.178  -5.775  0.000 
BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; ABCA-1: ATP-binding cassette trans-
porter A1; ACAT-1: acyl-CoA:cholesterol acyltransferase-1; LDL-R: low density lipoprotein receptor; LIPC: hepatic lipase gene; LIPG: en-
dothelial lipase gene; MTHFR: methylenetetrahydrofolate reductase; PCSK9: proprotein convertase subtilisin-like kexin type 9; PPARD: 
peroxisome proliferator-activated receptor delta; SCARB1: Scavenger receptor class B type 1. Int. J. Biol. Sci. 2012, 8 
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Discussion 
In the present study, we showed that the geno-
typic  frequencies  of  ACAT-1  and  LIPG,  the  allelic 
frequencies of ABCA-1, and the genotypic and allelic 
frequencies  of  LDL-R,  LIPC,  PPARD  and  SCARB1 
were  different  between  nonsmokers  and  smokers. 
These results indicate that several lipid-related genes 
may also involve in the regulation of blood pressure. 
In  the  current  study,  our  study  population,  Bai  Ku 
Yao, is an isolated subgroup of the Yao minority in 
China.  Strict  intra-ethnic  marriages  have  been  per-
formed in this population from time immemorial. But 
they can not intermarry within the direct descendant 
blood kin and the collateral branch blood kin in seven 
generations  [2,3,31,32].  Thus,  this  population  is 
thought  to  share  the  same  ethnic  ancestry  and  to 
possess  a  homogeneous  genetic  background.  Alt-
hough genetic variants in some genes have been as-
sociated with risk of hypertension in some studies, the 
results  of  these  association  studies  conducted  with 
blood pressure traits are inconsistent [8-16]. 
The association of these SNPs and blood pres-
sure levels between nonsmokers and smokers has not 
yet been thoroughly studied. In the present study, we 
showed that the levels of PP in nonsmokers were dif-
ferent among the three genotypes of ABCA-1, and the 
levels of SBP, DBP and PP in nonsmokers were also 
different  among  the  three  genotypes  of  LIPC.  The 
levels  of  SBP  in  smokers  were  different  among  the 
three  genotypes  of  ABCA-1,  ACAT-1,  LIPG  and 
PCSK9, the levels of DBP were different among the 
three genotypes of ACAT-1, LDL-R, LIPC, PCSK9 and 
PPARD, and the levels of PP were different among the 
three genotypes of LIPC, LIPG, MTHFR and PCSK9. 
To the best of our knowledge, the association between 
ABCA-1  V825I,  ACAT-1  rs1044925,  LIPC  -250G>A, 
LIPG  584C>T,  PCSK9  E670G,  and  SCARB1  rs5888 
SNPs and blood pressure variation has not been pre-
viously explored. 
The association of LDL-R AvaII, MTHFR C677T 
and PPARD +294T>C SNPs and blood pressure vari-
ation has been evaluated in several previous studies 
[41-55]. However, the findings are inconsistent. Liu et 
al.  [41]  found  that  there  were  no  differences  in  the 
genotypic and allelic frequencies of LDL-R AvaII be-
tween normotensives and essential hypertensives in 
Shanghai. Rodríguez-Esparragón et al. [42] reported 
that  TT  genotype  of  MTHFR  C677T  was  associated 
with  an  increased  risk  of  hypertension  in  males.  A 
previous  meta-analysis  showed  that  the  MTHFR 
C677T was consistently associated with severe dias-
tolic  hypertension  during  pregnancy  [43].  The 
MTHFR  C667T  modulated  baseline  DBP  and  DBP 
responsiveness by short-term treatment of benazepril 
[44,45].  A  significant  association  between  MTHFR 
C677T and hypertension/hypertension-in-pregnancy 
in  both  Caucasian  and  Asian  populations  was  also 
observed in a recent meta-analysis [46]. The patients 
carrying MTHFR 677T allele were at increased risk of 
hypertension.  The  frequency  of  co-occurrence  of 
MTHFR 677CT/1298CC genotypes was significantly 
higher in the patients compared to controls (P < 0.05) 
and was associated with increased risk of hyperten-
sion [47]. Marinho et al. [48] showed that genotype 
distribution of MTHFR differed significantly between 
control  and  hypertensive  patients  with  a  greater 
prevalence of CT genotypes. The MTHFR 677C allele 
was significantly more frequent in controls compared 
with patients with essential hypertension (P < 0.05), 
and  CC  genotype  was  more  frequent  in  controls 
compared to patients with essential hypertension [49]. 
However, several studies showed that there were no 
associations of MTHFR C677T and the prevalence of 
hypertension or blood pressure levels [50-52]. Gao et 
al. [53] reported that PPAR-gamma2 SNP is associated 
with  hypertension  in  the  Han  population  of  Inner 
Mongolia. The frequency of Ala allele was lower in 
patients  with  hypertension  (1.3%)  than  in  controls 
(3.6%,  P  =  0.018).  The  Pro12Ala  polymorphism  in 
PPAR-gamma was associated with blood pressure in 
subjects  with  type  2  diabetes.  The  subjects  with 
Pro/Ala (24%) or Ala/Ala (2%) had lower DBP when 
adjusted for age and gender compared with Pro/Pro 
subjects (74%). This association was restricted to men, 
who  also  had  a  borderline  significant  difference  in 
SBP [54]. However, Yan et al. [55] reported that the 
frequencies of the PPARD +294T>C genotypes were 
not  different  among  the  groups  of  metabolic  syn-
drome, essential hypertension, and type 2 diabetes. 
The  interactions  of  these  SNPs  and  cigarette 
smoking on blood pressure levels are not fully known. 
In the present study, the genotypes of ABCA-1 GG 
and GA and ACAT-1 AA and AC were shown inter-
actions with cigarette smoking to increase SBP levels, 
whereas the genotype of PCSK9 AG was shown in-
teractions  with  cigarette  smoking  to  decrease  SBP 
levels. The genotypes of ACAT-1 AA and AC, LDL-R 
A-A-,  A-A+  and  A+A+,  MTHFR  CC  and  CT,  and 
PCSK9 AA were shown consistent interactions with 
cigarette smoking to increase DBP levels. The geno-
types of ABCA-1 GA and LIPC GG were shown in-
teractions with cigarette smoking to increase PP lev-
els, whereas the genotypes of PCSK9 AA and AG, and 
PPARD  CC  were  shown  interactions  with  cigarette 
smoking to decrease PP levels. These findings suggest 
that  some  blood  pressure  parameters  in  our  study 
subjects were partly influenced by the interactions of Int. J. Biol. Sci. 2012, 8 
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several SNPs and cigarette smoking. Smoking cessa-
tion  and  other  healthy  lifestyles  are  necessary  for 
maintaining of normal blood pressure. The effect of 
different types of cigarettes on blood pressure levels is 
not well known. In our current study, 95% of the cig-
arettes smoked by the subjects were natural tobacco 
leaves, which the toxin content may be high. Tobacco 
smoke is a complex mixture of over 4,000 chemical 
constituents. There are many toxins in cigarette smoke 
such  as  nicotine,  cadmium,  carbon  monoxide,  and 
reactive oxygen species that might contribute to the 
cardiovascular toxicity [56]. Thus, the interactions of 
SNPs and different kinds of cigarettes on blood pres-
sure levels still need to be determined. 
Study Limitations 
The present study has several potential limita-
tions. First, we did not match smokers and nonsmok-
ers in terms of sex; therefore, the smokers had a much 
higher proportion of males than did the nonsmokers. 
Among  young  and  middle-aged  adults,  population 
surveys  have  shown  hypertension  to  be  more  fre-
quent among males than females, with sex differences 
of 4% in the United States, 8% in Canada, and 11% in 
Western  Europe  [57].  Second,  the  levels  of  average 
age,  height,  weight,  waist  circumference,  and  the 
percentages of subjects who consumed alcohol were 
higher in smokers than in nonsmokers. Although sex, 
age,  education  level,  physical  activity,  BMI,  waist 
circumference,  alcohol  consumption,  and  hyper-
lipidemia have been adjusted for the statistical analy-
sis, we could not completely eliminate the potential 
effects of these factors on blood pressure levels among 
different  genotypes  in  both  groups.  Third,  the  diet 
was  not  adjusted  for  the  statistical  analysis.  In  the 
present study, however, the diet in this population is 
consistent throughout the year and among individu-
als because of the Bai Ku Yao’s reliance on a limited 
number of locally available food items. Their staple 
food is corn gruel or corn tortillas. On ordinary days, 
they are vegetarians [2,3]. Finally, it is clearly estab-
lished  that  blood  pressure  levels  are  regulated  by 
multiple environmental and genetic factors, and their 
interactions. Although we have detected the interac-
tions of nine SNPs and cigarette smoking on blood 
pressure levels in this study, there are still many un-
measured environmental and genetic factors and their 
interactions.  Thus,  the  interactions  of  gene-gene, 
gene-environment, and environment-environment on 
blood pressure levels remain to be determined. 
Conclusion 
Several  lipid-related  gene  polymorphisms  in 
nonsmokers and smokers were found to be associated 
with blood pressure levels in the Guangxi Bai Ku Yao 
population. The interactions of ABCA-1 AA and AC 
and  ACAT-1  AA  and  AC  genotypes  and  cigarette 
smoking  to  increase  SBP,  and  PCSK9  AG  genotype 
and cigarette smoking to decrease SBP; ACAT-1 AA 
and AC, LDL-R A-A-, A-A+ and A+A+, MTHFR CC 
and  CT,  and  PCSK9  AA  genotypes  and  cigarette 
smoking to increase DBP levels; and ABCA-1 GA and 
LIPC GG genotypes and cigarette smoking to increase 
PP, and PCSK9 AA and AG, and PPARD CC geno-
types  and  cigarette  smoking  to  decrease  PP  levels 
were  also  detected.  The  observed  associations  and 
interactions between these SNPs and blood pressure 
variation in this isolated ethnic subgroup may also be 
the major characteristics of this condition in the other 
ethnic groups, especially in the minorities. However, 
large studies of populations with different ethnic ori-
gins are required to confirm these observations. 
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